Skip to main content

Increase in Medical Emergencies and Physical Injuries to Boost the Emergency Medical Equipment Market Growth

 


Emergency medical equipment is an integral part of the healthcare industry. It includes specialized products and equipment to assist in the provision of emergency care. Emergency medical equipment help in monitoring patients in uncontrolled environments in a pre-hospital setting. Several medical emergencies and physical injuries such as trauma are life-threatening and require quick medical attention. Thus, the increasing incidence of medical emergencies and trauma injuries create significant growth opportunities for the market. In the United States, around 3 million non-fatal injuries occur each year, causing more than 150,000 deaths, according to the American Association for the Surgery of Trauma.

The geriatric population is more prone to various medical emergencies such as respiratory diseases, cardiac arrest, and other medical urgency. According to the World Health Organization, the world's population aged 60 years and older is expected to total 2 billion by 2050, up from 900 million in 2015. Today, 125 million people are aged 80 years or older. Moreover, increasing demand for emergency medical equipment and well-established healthcare facilities are also expected to drive the emergency medical equipment market growth. However, improper functioning (leads to product recall) and the high cost of equipment is expected to restrain the market growth.

Based on type, the market can be classified into patient handling equipment, infection control supplies, wound care consumables, emergency resuscitation equipment, patient monitoring systems, personal protection equipment, and others. Moreover, recent improvements in critical patient care and sudden infectious outbreaks, including COVID-19, will contribute to the tremendous demand for emergency medical equipment. As of December 23, the virus has infected more than 78 million people worldwide, and thus, the demand for emergency medical equipment from COVID-19 affected countries has increased, driving the market growth. Various efforts and initiatives are being taken by organizations and industry leaders to meet the unprecedented need.

Technological advancements coupled with infrastructure development, as well as increasing government funding, is also expected to increase the demand for such equipment. In terms of geography, the emergency medical equipment market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Key players active in the market are adopting various strategies (such as product launch, mergers and acquisition, etc.) to strengthen their market presence. For example, in April 2020, Stryker launched emergency relief beds to provide efficient care solutions during the pandemic. Moreover, in June 2018, Royal Phillips acquired Remote Diagnostic Technologies to strengthen its market presence in the resuscitation and emergency care industry.

 

Comments

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  

Immuno-oncology: Combination Therapies and Emerging Targets

  The study of and creation of therapies that use the immune system of the body to combat cancer are known as immuno-oncology. Our immune system, which is made up of a complex web of organs, cells, and molecules, guards us against external invaders like bacteria, fungus, and viruses that might infect us. The immune system is capable of locating and eliminating foreign objects as well as attacking aberrant cells. The immune system has the best chance of specifically destroying tumours without harming healthy tissue and having long-term memory that can stop cancer from coming back. The development of tumours can be permanently prevented or managed by a mechanism known as immunosurveillance, according to research in immuno-oncology conducted over the past 30 years. Recognition of tumour antigens is what gives the immune response its tumour specificity. The most well-established therapeutic class of IO drugs to date, immune checkpoint inhibitors have demonstrated significant effic...